AB0676 CROSS-EVALUATIONS OF DISEASE ACTIVITIES AND JOINT AFFECT RATIO AFTER BIOLOGICAL OR TARGETED S...
AB0676 CROSS-EVALUATIONS OF DISEASE ACTIVITIES AND JOINT AFFECT RATIO AFTER BIOLOGICAL OR TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS USING THE SIMPLIFIED DISEASE ACTIVITY INDEX SCORE AND THE JOINT INDEX VECTOR SCORES
About this item
Full title
Author / Creator
Yoshii, I. , Nishiyama, S. , Sawada, N. and Chijiwa, T.
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
Background:Joint Index Vector (JIV) was developed by Nishiyama1), which evaluates only joint involvement in the whole body of the patient with rheumatoid arthritis (RA), presenting a 3-dimensional coordinate axis. This index is available due to a strong correlation with disease activity, functional ability, and pain status2)3).Objectives:We tried t...
Alternative Titles
Full title
AB0676 CROSS-EVALUATIONS OF DISEASE ACTIVITIES AND JOINT AFFECT RATIO AFTER BIOLOGICAL OR TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS USING THE SIMPLIFIED DISEASE ACTIVITY INDEX SCORE AND THE JOINT INDEX VECTOR SCORES
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3100961906
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3100961906
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2024-eular.1545
